Free shipping over $99 | Interest Free *no credit check* financing is available!

Researchers Have Successfully Figured Out How To Edit HIV Out Of T Cells

by Graham Gremore March 25, 2016


This is huge.

Researchers at Temple University in Philadelphia say they have found a safe way to eliminate the HIV-1 virus from CD4+ T cells through a gene editing system.

Related: What Every Young Person Should Know About The HIV/AIDS Stigma Gay Men Faced In The ’80s

“The findings are important on multiple levels,” Kamel Khalili, professor and chair of the Department of Neuroscience at Temple, says in a statement. “They demonstrate the effectiveness of our gene editing system in eliminating HIV from the DNA of CD4+ T-cells and, by introducing mutations into the viral genome, permanently inactivate viral replication.”

“Further,” Khalili continued, “they show that the system can protect cells from reinfections and that the technology is safe for the cells, with no toxic effects.”

The findings were published in Scientific Reports earlier this week and mark the first time researchers at Temple have actually been able to remove HIV from an infected T cell, opening the door for even more in-depth research.

“The questions they address are critical, and the results allow us to move ahead with this technology,” Khalili said.

Related: CDC: Half Of Gay Black Americans Will Get HIV

In a press release, Dr. Thomas Malcolm, CEO and President of Excision Biotherapeutics, which holds the exclusive rights to commercialize the gene editing technology, said: “This is a major advance in safety and efficacy for the use of CRIPSR/Cas9 gRNA HIV eradication for us in humans. These exciting results also reflect our ability to select viral gene targets for safe eradication of any viral genome in our current pipeline of gene editing therapeutics.”

Gene editing has long been thought of as a potential cure for HIV, but scientists have feared that if not done properly, the side effects could be disastrous, even fatal. Researchers at Temple believe they have overcome this hurdle, but they are careful to note that challenges remain.

“First, it will be important to maximize elimination of viral sequences from patients,” the authors state. “This will require analysis of the HIV-1 quasi-species harbored by patients’ CD4+ T-cells and design of suitable, i.e. personalized CRISPRs. Second, improved delivery of CRISPR/Cas9 will be required to target the majority of circulating T-cells.”

Related: Five Things You Don’t Know About The First Man Cured Of HIV

h/t: HIV Equal

Graham Gremore
Graham Gremore


Leave a comment

Comments will be approved before showing up.

Also in Think

Aaron Carter Opens Up About His Problems With Drug Addiction And Depression

by Derek de Koff October 24, 2016

In a rare television interview, 28-year-old Aaron Carter appeared on Oprah: Where Are They Now to open up about the host of well-documented personal problems that came along with his meteoric success as a pop star in the late ’90s. The precipitating event was the abrupt divorce of his parents; an announcement made mere minutes before he was set to [...]

Continue Reading →

Here’s The Photo That Nearly Got David McIntosh Banned From Instagram

by Dan Tracer October 24, 2016

When you have a body like this, you should probably just go ahead and do everything sans clothing. McIntosh knows: “If you appreciate your body, why would you want to cover it up? You might as well show it off.” Agreed. “I live in an apartment with buildings facing onto it, so when I walk [...]

Continue Reading →

DVD: “Independence Day: Resurgence,” “Front Cover,” “Michael Moore In Trumpland,” & More!

by Lawrence Ferber October 24, 2016

Aliens, exes, and culture clashes, oh my! It seems like a lot of worlds get shaken up in this week’s home entertainment picks. Those rascally world-conquering aliens are back in Roland Emmerich’s long-awaited sequel to ID4, Independence Day: Resurgence. A gay Asian-American New Yorker clashes, and finds sparks with, a closeted actor from Beijing in [...]

Continue Reading →